These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1264)

  • 41. Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site.
    Kemp RG
    Biochemistry; 1969 Aug; 8(8):3162-8. PubMed ID: 4241302
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemical modification of allosteric properties of enzymes.
    Kemp RG
    Biol Res; 1996; 29(1):47-56. PubMed ID: 9267516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of allosteric ligands on the activity and aggregation of rabbit muscle phosphofructokinase.
    Lad PM; Hill DE; Hammes GG
    Biochemistry; 1973 Oct; 12(22):4303-9. PubMed ID: 4270764
    [No Abstract]   [Full Text] [Related]  

  • 44. The kinetics of effector binding to phosphofructokinase. The binding of Mg2+-1,N6-ethenoadenosine triphosphate to the catalytic site.
    Roberts D; Kellett GL
    Biochem J; 1980 Sep; 189(3):561-7. PubMed ID: 6260083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of ammonium, inorganic phosphate and potassium ions on the activity of phosphofructokinases from muscle and nervous tissues of vertebrates and invertebrates.
    Sugden PH; Newsholme EA
    Biochem J; 1975 Jul; 150(1):113-22. PubMed ID: 128356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique PFK regulatory property from some mosquito vectors of disease, and from Drosophila melanogaster.
    Nunes RD; Romeiro NC; De Carvalho HT; Moreira JR; Sola-Penna M; Silva-Neto MA; Braz GR
    Parasit Vectors; 2016 Feb; 9():107. PubMed ID: 26911930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The control of rat-heart phosphofructokinase by citrate and other regulators.
    Pogson CI; Randle PJ
    Biochem J; 1966 Sep; 100(3):683-93. PubMed ID: 4291039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Desensitization of muscle phosphofructokinase to ATP inhibition by removal of a carboxyl-terminal heptadecapeptide.
    Valaitis AP; Foe LG; Kemp RG
    J Biol Chem; 1987 Apr; 262(11):5044-8. PubMed ID: 2951376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distances between structural metal ion, substrates, and allosteric modifier of fructose bisphosphatase.
    Cunningham BA; Raushel FM; Villafranca JJ; Benkovic SJ
    Biochemistry; 1981 Jan; 20(2):359-62. PubMed ID: 6258638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation by phosphate of yeast phosphofructokinase.
    Bañuelos M; Gancedo C; Gancedo JM
    J Biol Chem; 1977 Sep; 252(18):6394-8. PubMed ID: 19473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic behaviour and regulatory properties of phosphofructokinase in rat bone marrow cells.
    Tejedor MC; Ramírez A; Luque J
    Biochem Int; 1984 Nov; 9(5):577-86. PubMed ID: 6098275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of phosphofructokinase with antibodies. Kinetic properties of phosphofructokinase in complexes with antibodies.
    Bartholomé-Dönnicke M; Hofer HW
    Biochim Biophys Acta; 1975 Aug; 397(2):347-54. PubMed ID: 125608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of ATP and of 1,N6-ethenoadensone triphosphate to rabbit muscle phosphofructokinase.
    Liou RS; Anderson SR
    Biochemistry; 1978 Mar; 17(6):999-1004. PubMed ID: 147103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inorganic phosphate amplifies the effects of AMP and fructose-2,6-bisphosphate on yeast phosphofructokinase.
    Przybylski F; Nissler K; Schellenberger W; Hofmann E
    Biomed Biochim Acta; 1985; 44(11-12):1559-65. PubMed ID: 2936338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The control of pyruvate kinase of Escherichia coli. Binding of substrate and allosteric effectors to the enzyme activated by fructose 1,6-bisphosphate.
    Waygood EB; Mort JS; Sanwal BD
    Biochemistry; 1976 Jan; 15(2):277-82. PubMed ID: 764863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of phosphate chain mobility of MgATP in completing the 3-phosphoglycerate kinase catalytic site: binding, kinetic, and crystallographic studies with ATP and MgATP.
    Flachner B; Kovári Z; Varga A; Gugolya Z; Vonderviszt F; Náray-Szabó G; Vas M
    Biochemistry; 2004 Mar; 43(12):3436-49. PubMed ID: 15035615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substrate antagonism in the kinetic mechanism of E. coli phosphofructokinase-1.
    Deville-Bonne D; Laine R; Garel JR
    FEBS Lett; 1991 Sep; 290(1-2):173-6. PubMed ID: 1833241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory properties of 6-phosphofructokinase and control of glycolysis in boar spermatozoa.
    Kamp G; Schmidt H; Stypa H; Feiden S; Mahling C; Wegener G
    Reproduction; 2007 Jan; 133(1):29-40. PubMed ID: 17244730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ligand-induced conformational transitions in Escherichia coli phosphofructokinase 2: evidence for an allosteric site for MgATP2-.
    Guixé V; Rodríguez PH; Babul J
    Biochemistry; 1998 Sep; 37(38):13269-75. PubMed ID: 9748334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.